Our translational science
We're tackling the biggest challenges in developing cancer treatments with our innovative approach to drug discovery and development.
Our bold drug discovery model embraces risk to drive forward early-stage projects, with a focus on creating a pipeline of breakthrough medicines for cancer patients.

Expertise spanning drug discovery and development
We build on Cancer Research UK's impressive track record of innovative research to bridge the gap between academia and the life science industry. We're committed to driving therapeutic innovation in oncology, with six drug discovery sites and one focus: accelerating the discovery and development of new therapeutics.
Our news
28 January 2025
23 January 2025
Cancer Research UK, Cytovation and the Norwegian Cancer Society collaborate to advance treatment for rare cancer
16 January 2025
Protein level predicts immunotherapy response in bowel cancer
Want to know more about our scientific capabilities and drug discovery approaches?
We're seeking new partnerships to advance the next generation of cancer medicines.